GenomesDao price

GENOME

#3700

GenomesDao (GENOME) is revolutionizing the genomic data landscape by providing a platform for the safe, private, and auditable monetization of genomic data. This innovative project, spearheaded by Genomes.io, a genomic data security company founded in 2018 and based in London, UK, leverages cutting-edge technologies like AMD's Secure Encrypted Virtualization (SEV), blockchain, and decentralized finance (DeFi) to enhance data sovereignty and privacy protections.

At the heart of GenomesDao is the belief that individuals should own their genomic data. By creating a private and secure DNA data bank, GenomesDao empowers users to control their genome, addressing critical privacy, security, and ownership concerns associated with DNA testing and sharing. This initiative aims to build the world's largest user-owned genomic data bank, securing the future of personalized medicine.

The GENOME token is a deflationary utility token used by pharmaceutical companies and research organizations to query genomic data. Genomes.io acts as a broker for these queries, allowing individuals to approve or deny access to their data. Data buyers can set the price for each query, which is translated into GENOME tokens, adding value to the tokens and incentivizing data sharing.

By integrating decentralized science (DeSci) and DeFi, GenomesDao aims to democratize and decentralize genomic studies, solving the industry's current issues of data sovereignty and privacy. Pharmaceutical companies are incentivized to purchase GENOME tokens, fostering a secure and efficient ecosystem for genomic data monetization.

The technology behind GenomesDao is a fascinating blend of advanced technologies designed to ensure the privacy, security, and ownership of genomic data. At its core, GenomesDao operates on the Ethereum blockchain, a decentralized platform that provides a secure and transparent ledger for transactions. This blockchain is pivotal in preventing attacks from bad actors through its consensus mechanism, which requires multiple nodes to agree on the validity of transactions, making it extremely difficult for any single entity to manipulate the data.

In addition to the robust security provided by the Ethereum blockchain, GenomesDao leverages AMD's Secure Encrypted Virtualization (SEV-ES) technology. This cutting-edge technology ensures that genomic data is stored and processed in a secure environment, protecting it from unauthorized access. SEV-ES encrypts the data in memory, making it inaccessible even to the system administrators, thereby adding an extra layer of security.

GenomesDao also introduces the concept of a DNA Vault, a secure and participant-owned genomic database. This vault allows individuals to store their genomic data securely and decide who can access it. The DNA Vault technology addresses the privacy and ownership concerns that are often associated with DNA testing and sharing. By giving users control over their genomic data, GenomesDao aims to build the world's largest user-owned genomic data bank, paving the way for personalized medicine.

The GENOME token plays a crucial role in the ecosystem of GenomesDao. This deflationary utility token is used for monetization and governance purposes. Pharmaceutical companies and research organizations can offer GENOME tokens to users in exchange for querying their genomic data. The queries are brokered by GenomesDao, and users have the autonomy to approve or reject these queries. This system not only incentivizes users to share their data but also ensures that they are compensated fairly.

Furthermore, the decentralized finance (DeFi) aspect of GenomesDao allows for a transparent and efficient marketplace for genomic data. Data buyers, such as pharmaceutical companies and research organizations, can set the price they are willing to pay for each query. This price is translated into GENOME tokens, ensuring cost-effectiveness and value for both the data providers and buyers.

By combining blockchain technology, AMD SEV-ES, and decentralized finance, GenomesDao creates a secure, private, and user-centric platform for genomic data. This innovative approach not only protects the data from unauthorized access but also empowers individuals to take control of their genetic information, fostering a new era of personalized medicine.

GenomesDao (GENOME) is a groundbreaking initiative that leverages blockchain technology to revolutionize the way genomic data is managed and utilized. At its core, GenomesDao aims to democratize and decentralize genomic studies, ensuring that individuals retain control over their genetic information.

One of the primary real-world applications of GenomesDao is the creation of secure, participant-owned genomic databases. This allows organizations to access high-quality genomic datasets while ensuring that the data remains private and secure. By using blockchain technology, GenomesDao ensures that data transactions are transparent and tamper-proof, addressing significant privacy and security concerns associated with DNA testing and sharing.

For researchers, GenomesDao offers a valuable resource by providing access to extensive genomic datasets. This access is crucial for advancing personalized medicine, as researchers can analyze genetic information to develop targeted treatments and therapies. Pharmaceutical companies and research organizations can query this data, with the cost of these queries being translated into GENOME tokens. This system not only incentivizes data sharing but also ensures that individuals are compensated for their contributions.

The general public also benefits from GenomesDao through personalized genomic reports and secure data storage. Individuals can receive insights into their genetic makeup, which can inform health and lifestyle decisions. Additionally, the secure storage of genomic data means that individuals can control who accesses their information and for what purpose.

Another significant application of GenomesDao is in the realm of genetic identity control. By owning their genomic data, individuals can prevent unauthorized use and ensure that their genetic information is used ethically and responsibly. This control is facilitated through the use of GENOME tokens, which act as a medium of exchange for data queries and transactions.

In the broader context of cryptocurrency, GenomesDao enables trading on exchanges, allowing users to earn money by participating in the ecosystem. The deflationary nature of GENOME tokens adds an economic dimension, making them valuable for various stakeholders, including those in healthcare, finance, and governance sectors.

By addressing privacy, security, and ownership concerns, GenomesDao is building the world's largest user-owned genomic data bank, securing the future of personalized medicine and empowering individuals to take control of their genetic information.

GenomesDao is a pioneering platform that empowers individuals to monetize their genomic data through decentralized finance (DeFi) and decentralized science (DeSci). The GENOME token facilitates data queries, allowing pharmaceutical companies and research organizations to offer compensation for access to this valuable information.

One of the significant milestones for GenomesDao was securing funding from prominent web3 venture capital firms, Pantera Capital and Modular Capital. This investment underscored the potential and credibility of GenomesDao within the blockchain and genomic data sectors. The backing from such influential VCs provided the necessary resources to further develop and expand their platform.

Another notable event was the mention by Binance Research, which brought considerable attention to GenomesDao. This recognition from a leading entity in the cryptocurrency space highlighted the innovative approach of GenomesDao in integrating blockchain technology with genomic data management. The mention helped in increasing visibility and credibility among potential users and investors.

GenomesDao also made a significant technological advancement with the implementation of DNA Vault technology. This secure and participant-owned genomic database ensures that individuals have complete control over their genomic data. The DNA Vault leverages advanced security measures, including AMD Secure Encrypted Virtualization (SEV) technology, to protect the privacy and integrity of the data stored within the platform.

The platform's core philosophy is that individuals should own their genomic data, addressing privacy, security, and ownership concerns associated with DNA testing and sharing. By building the world's largest user-owned genomic data bank, GenomesDao aims to secure the future of personalized medicine. This approach not only empowers individuals but also facilitates more accurate and personalized healthcare solutions.

The GENOME token, a deflationary utility token, plays a crucial role in the ecosystem. It is used by pharmaceutical companies and research organizations to query genomic data. Genomes.io acts as a broker for these queries, and individuals have the autonomy to approve or deny access to their data. This model ensures that data buyers can set prices for queries, which are then translated into GENOME tokens, providing a cost-effective solution for both parties.

These key events and technological advancements have positioned GenomesDao as a leader in the intersection of blockchain technology and genomic data management. The platform continues to innovate and expand, driven by its mission to give individuals control over their genomic data and to facilitate advancements in personalized medicine.